| Species : | 
                                    Human | 
                                
                                
                                    | Source : | 
                                    Nicotiana Benthamiana | 
                                
                                
                                    | Tag : | 
                                    Non | 
                                
                                
                                    | Description : | 
                                    Recombinant human TFPI-2 domain 1 or AGV 212 is a protease inhibitor peptide generated from the first Kunitz domain of the human Tissue Factor Protein Inhibitor 2 (TFPI-2) protein, after site-directed mutagenesis to increase its activity. It is arranged in a single polypeptide chain that is linked by three disulphide bridges. AGV 212 is quite stable and inhibits trypsin with high efficiency and Ki lower than TFPI-2 one. TFPI-2 has been shown to inhibit Endothelial Cell Matrix (ECM) proteases essential for angiogenesis and metastasis. | 
                                
                                
                                    | Form : | 
                                    Lyophilized powder containing phosphate buffer salts, pH 7.1. | 
                                
                                
                                    | Bio-activity : | 
                                    The activity of the inhibitor is expressed as the amount of trypsin inhibited per milligram of inhibitor. The ability to prevent the hydrolysis of benzoyl-L-arginine ethyl ester hydrochloride by trypsin is measured by spectrophotometer. One mg protein will inhibit 1-1.5 mg trypsin with activity of approximately 10,000 BAEE units per mg protein. | 
                                
                                
                                    | Molecular Mass : | 
                                    Recombinant human TFPI-2 domain 1, is a 9.3 kDa protein containing 79 amino acids residues. | 
                                
                                
                                    | AA Sequence : | 
                                    HHHHHHGAAQEPTGNNAEICLLPLDYGPCKALLLRYYYDRYTQSCRQFLYGGCEGNANNFYTWEACDDACWRIEK VPKV | 
                                
                                
                                    | Endotoxin : | 
                                    < 0.04="" eu="" ug="" protein="" (lal=""> | 
                                
                                
                                    | Purity : | 
                                    >97% by SDS-PAGE gel | 
                                
                                
                                    | Applications : | 
                                    Trypsin inhibitor, Western blot, Immunogen | 
                                
                                
                                    | Storage : | 
                                    This lyophilized preparation is stable at 2-8°C, but should be kept at –20°C for long term storage. Diluted solutions are less stable than concentrated ones. Repeated freezing and thawing is not recommended. | 
                                
                                
                                    | Reconstitution : | 
                                    Lyophilized protein should be reconstituted adding 1 ml of sterile water to the vial, which gives a concentration of 1 mg of protease inhibitor per ml. At higher concentration the solubility may be reduced and multimers generated. Soluble in water and in aqueous buffers of low ionic strengths. Repeated freeze-thaw cycles should be avoided. Optimal reconstitution please follow batch Quality Control sheet instructions. |